Found: 4
Select item for more details and to access through your institution.
Blood natural killer cells during treatment in recurrent ovarian cancer.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 11, p. 1365, doi. 10.1080/0284186X.2020.1791358
- By:
- Publication type:
- Article
Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 6, p. 652, doi. 10.1080/0284186X.2019.1711173
- By:
- Publication type:
- Article
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy.
- Published in:
- Journal of Ovarian Research, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13048-020-00661-4
- By:
- Publication type:
- Article
Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1766, doi. 10.3390/cancers14071766
- By:
- Publication type:
- Article